Compounds, Compositions And Methods For Cancer Treatment

Patent No. EP3576742 (titled "Compounds, Compositions And Methods For Cancer Treatment") was filed by Bayer on Feb 1, 2018. The application was issued on Jul 2, 2025.

Patent Family

Statuses, jurisdictions and citation links are shared on request.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

May 7, 2026
Communication regarding the expiry of opposition period
Jul 15, 2025
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jun 5, 2025
Decision to grant a European patent
May 21, 2025
(Electronic) Receipt
May 21, 2025
Filing of the translations of the claims
May 21, 2025
French translation of claims
May 21, 2025
German translation of the claims
Mar 11, 2025
Letter relating to the revocation of the automatic debiting procedure
Mar 10, 2025
Communication of amended entries concerning the representative
Mar 10, 2025
Miscellaneous requests concerning client data
Mar 6, 2025
Communication concerning the filing of a power of attorney
Mar 3, 2025
(Electronic) Receipt
Mar 3, 2025
Letter accompanying subsequently filed items
Mar 3, 2025
Submission concerning change of applicant's representative
Jan 24, 2025
Annex to the communication about intention to grant a European patent
Jan 24, 2025
Bibliographic data of the European patent application
Jan 24, 2025
Communication about intention to grant a European patent
Jan 24, 2025
Intention to grant (signatures)
Jan 24, 2025
Text intended for grant (clean copy)
Jan 24, 2025
Text intended for grant (version for approval)
Aug 31, 2023
(Electronic) Receipt
Aug 31, 2023
Amended claims with annotations
Aug 31, 2023
Amended description with annotations
Aug 31, 2023
Claims
Aug 31, 2023
Description
Aug 31, 2023
Letter accompanying subsequently filed items
Aug 31, 2023
Reply to communication from the Examining Division
Apr 24, 2023
Annex to the communication
Apr 24, 2023
Communication from the Examining Division
Mar 30, 2022
Document concerning representation
Dec 10, 2020
(Electronic) Receipt
Dec 10, 2020
Amended claims with annotations
Dec 10, 2020
Claims
Dec 10, 2020
Letter accompanying subsequently filed items
Dec 10, 2020
Reply to communication from the Examining Division
Aug 26, 2020
Annex to the communication
Aug 26, 2020
Communication from the Examining Division
Aug 20, 2020
Examination started
Mar 5, 2020
(Electronic) Receipt
Mar 5, 2020
Amended claims filed after receipt of (European) search report
Mar 5, 2020
Amended claims with annotations
Mar 5, 2020
Amendments received before examination
Nov 13, 2019
Notification on forthcoming publication of bibliographic data
Sep 13, 2019
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Sep 11, 2019
Communication to designated inventor
Aug 19, 2019
Copy of the international preliminary report on patentability
Aug 5, 2019
Notification of the recording of a change
Aug 5, 2019
Notification of the recording of a change
Jul 25, 2019
(Electronic) Receipt
Jul 25, 2019
Amended claims filed after receipt of (European) search report
Jul 25, 2019
Request for entry into the European phase
Jul 17, 2019
(Electronic) Receipt
Jul 17, 2019
Incoming letter related to PCT RO
Jun 14, 2019
Information on entry into European phase
Aug 29, 2018
Priority document (electronically transmitted)
Aug 9, 2018
Converted Sequence Listing
Aug 9, 2018
Copy of the international search report
Aug 9, 2018
Published international application - A1
May 23, 2018
Communication in cases for which no other form is applicable
May 23, 2018
Communication in cases for which no other form is applicable
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
May 23, 2018
Notification of the recording of a change
Apr 20, 2018
ISR: cited documents
Apr 20, 2018
ISR: cited documents
Apr 19, 2018
Written opinion of the ISA, boxes No. I to VIII
Apr 19, 2018
Written opinion of the ISA, cover sheet
Apr 19, 2018
Written opinion of the ISA, supplemental box
Feb 27, 2018
Incoming letter related to PCT RO
Feb 26, 2018
Communication in cases for which no other form is applicable
Feb 26, 2018
Notification of receipt of Search copy
Feb 23, 2018
Notification of the international application number and of the international filing date
Feb 20, 2018
Request form for international application (copy for ISA/EP)
Feb 1, 2018
(Electronic) Receipt
Feb 1, 2018
Abstract
Feb 1, 2018
Claims
Feb 1, 2018
Description
Feb 1, 2018
Document concerning fees and payments
Feb 1, 2018
Drawings
Feb 1, 2018
Electronic request for grant of an International application

EP3576742

BAYER

Application Number: EP18704189A
Filing Date: Feb 1, 2018
Status: Granted And Under Opposition; May 29, 2025
Publication Date: Jul 2, 2025
External Links: Slate, Register , Google Patents

IP Verse

Compounds, Compositions And Methods For Cancer Treatment

Patent Summary

Patent Family

Dossier Documents

EP3576742